ProMIS Neurosciences (PMN) Change in Account Payables (2021 - 2026)

ProMIS Neurosciences (PMN) has 6 years of Change in Account Payables data on file, last reported at -$826591.0 in Q1 2026.

• Quarterly Change in Account Payables fell 53.84% year-over-year to -$826591.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $516662.0 (up 353.98% YoY) and the FY2025 annual result came in at $805952.0, up 113.2% from the prior year.
• Change in Account Payables grew to -$826591.0 in Q1 2026, from -$1.7 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $4.0 million in Q1 2023 to a low of -$6.4 million in Q1 2024.
• A 5-year average of $88976.4 and a median of $264774.0 in 2022 frame the typical range for Change in Account Payables.
• Annual changes were most pronounced in 2022 — Change in Account Payables soared 2500.93% — and 2025, when it slumped 1128.23%.
• Tracing PMN's Change in Account Payables over 5 years: stood at $1.2 million in 2022, then plunged by 141.13% to -$475981.0 in 2023, then jumped by 134.08% to $162228.0 in 2024, then tumbled by 1128.23% to -$1.7 million in 2025, then jumped by 50.45% to -$826591.0 in 2026.
• The last three Change in Account Payables figures came in at -$826591.0 (Q1 2026), -$1.7 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.